You are using an unsupported browser. This web site is designed for the current versions of Microsoft Edge, Google Chrome, Mozilla Firefox, or Safari.
The Office of the Federal Register publishes documents on behalf of Federal agencies but does not have any authority over their programs. We recommend you directly contact the agency associated with the content in question.
If you have comments or suggestions on how to improve the www.ecfr.gov website or have questions about using www.ecfr.gov, please choose the 'Website Feedback' button below.
If you would like to comment on the current content, please use the 'Content Feedback' button below for instructions on contacting the issuing agency
Enhanced content is provided to the user to provide additional context.
This content is from the eCFR and is authoritative but unofficial.
Navigate by entering citations or phrases (eg: 1 CFR 1.1 49 CFR 172.101 Organization and Purpose 1/1.1 Regulation Y FAR).
Choosing an item from citations and headings will bring you directly to the content. Choosing an item from full text search results will bring you to those results. Pressing enter in the search box will also bring you to search results.
Background and more details are available in the Search & Navigation guide.
The in-page Table of Contents is available only when multiple sections are being viewed.
Use the navigation links in the gray bar above to view the table of contents that this content belongs to.
52 FR 33355, Sept. 2, 1987, unless otherwise noted.
This content is from the eCFR and may include recent changes applied to the CFR. The official, published CFR, is updated annually and available below under "Published Edition". You can learn more about the process here.
Subscribe to: 21 CFR 886.4320
View the most recent official publication:
These links go to the official, published CFR, which is updated annually. As a result, it may not include the most recent changes applied to the CFR. Learn more.
Information and documentation can be found in our developer resources.
The Code of Federal Regulations (CFR) is the official legal print publication containing the codification of the general and permanent rules published in the Federal Register by the departments and agencies of the Federal Government. The Electronic Code of Federal Regulations (eCFR) is a continuously updated online version of the CFR. It is not an official legal edition of the CFR.
Learn more about the eCFR, its status, and the editorial process.
Nomenclature changes to part 886 appear at 73 FR 35341, June 23, 2008.
(a) Identification. Corneal storage medium with preservatives including antifungals is a device that is used to temporarily preserve human cornea tissue between harvesting and implantation.
(b) Classification. Class II (special controls). The special controls for this device are:
(1) Non-clinical performance testing must demonstrate that the device performs as intended under anticipated conditions of use.
(i) The following performance characteristics of the cornea following storage in the device must be demonstrated:
(A) Endothelial cell density;
(B) Endothelial cell morphology;
(C) Corneal transparency; and
(D) Central corneal thickness.
(ii) Antimicrobial activity of the device must be demonstrated at the initial and maximum labeled storage time.
(iii) Characterization of all preservatives, including antifungals, must include the following:
(A) Characterization of impurities, heavy metal analysis, concentration, and dissolution; and
(B) Chemical activity of all preservatives over the labeled use life of the device.
(2) Performance data must demonstrate the sterility of the device.
(3) The device must be demonstrated to be biocompatible and non-pyrogenic.
(4) Performance data must support the claimed shelf life by demonstrating continued sterility, controlled bioburden, package integrity, and device functionality over the intended shelf life.
(5) The device and each of its components (e.g., antifungal, antibiotic, medium) must be demonstrated to be compatible with their respective commercial container closure system/packaging.
(6) An analysis must be provided that identifies and evaluates any contribution to the development and spread of antimicrobial resistance.
(7) Labeling must include the following instructions:
(i) Rinsing of cornea prior to transplantation; and
(ii) Complete dissolution of all preservatives.
[91 FR 24347, May 6, 2026]